Market News

Jon Giacomin Sold 7995 shares of Cardinal Health, Inc. (CAH) in an Insider Trade; Macerich Co Has 0.95 Sentiment

As announced in a form that has been filled with the U.S. Security and Exchange Commission on 20/02/2018, Jon Giacomin an insider in Cardinal Health Inc and currently CEO – Medical Segment, unloaded shares worth $549,924 U.S. Dollars in the Ohio-based company. He sold 7,995 shares, at average $68.8 per share. Jon Giacomin now indirectly possess 0 shares. He also directly possess 55048 shares. In total he holds a stake of 0.02%.

The Macerich Company is an independent real estate investment trust. The company has market cap of $8.97 billion. The firm invests in the real estate markets of the United States. It has a 58.22 P/E ratio. It primarily engages in acquisition, ownership, development, redevelopment, management and leasing of regional and community shopping centers located throughout the United States.

The stock decreased 0.72% or $0.5 during the last trading session, reaching $68.84. About 2.36 million shares traded. Cardinal Health, Inc. (NYSE:CAH) has declined 4.95% since February 21, 2017 and is downtrending. It has underperformed by 21.65% the S&P500.

Investors sentiment increased to 0.9 in Q3 2017. Its up 0.03, from 0.87 in 2017Q2. It is positive, as 63 investors sold Cardinal Health, Inc. shares while 229 reduced holdings. 64 funds opened positions while 198 raised stakes. 275.05 million shares or 0.51% more from 273.65 million shares in 2017Q2 were reported. Principal Finance Grp Inc holds 0.03% or 469,077 shares. Whittier Com accumulated 7,453 shares or 0.02% of the stock. Martingale Asset Mngmt Limited Partnership reported 129,608 shares. Cadence Capital Mgmt Limited holds 65,205 shares. Cetera Advisor Netwr Ltd stated it has 0.02% in Cardinal Health, Inc. (NYSE:CAH). Alaska-based State Of Alaska Department Of Revenue has invested 0.07% in Cardinal Health, Inc. (NYSE:CAH). Jpmorgan Chase & accumulated 1.58M shares. Evercore Wealth Management Ltd Llc reported 0% in Cardinal Health, Inc. (NYSE:CAH). Glob Endowment Lp has 51,100 shares for 0.48% of their portfolio. Acg Wealth reported 5,353 shares. Seaward Mgmt Lp owns 3,236 shares for 0.01% of their portfolio. Brandywine Global Inv Mgmt Limited Com accumulated 43,074 shares. Invesco holds 8.20M shares or 0.2% of its portfolio. Captrust Fincl invested in 11,470 shares. Legal & General Grp Public Ltd Co has invested 0.1% of its portfolio in Cardinal Health, Inc. (NYSE:CAH).

Cardinal Health, Inc. operates as an integrated healthcare services and products firm worldwide. The company has market cap of $21.66 billion. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers. It has a 12 P/E ratio. It offers distribution, inventory management, data reporting, new product launch support, and chargeback administration services to pharmaceutical manufacturers; pharmacy and medication therapy management, and patient outcomes services to hospitals, other healthcare providers, and payers; and consulting, patient support, and other services to pharmaceutical manufacturers and healthcare providers.

Analysts await Cardinal Health, Inc. (NYSE:CAH) to report earnings on May, 7. They expect $1.51 EPS, down 1.31% or $0.02 from last year’s $1.53 per share. CAH’s profit will be $475.20M for 11.40 P/E if the $1.51 EPS becomes a reality. After $1.31 actual EPS reported by Cardinal Health, Inc. for the previous quarter, Wall Street now forecasts 15.27% EPS growth.

Among 20 analysts covering Cardinal Health (NYSE:CAH), 4 have Buy rating, 1 Sell and 15 Hold. Therefore 20% are positive. Cardinal Health has $107 highest and $64 lowest target. $80.54’s average target is 17.00% above currents $68.84 stock price. Cardinal Health had 48 analyst reports since August 10, 2015 according to SRatingsIntel. Leerink Swann maintained the stock with “Hold” rating in Monday, April 24 report. As per Tuesday, June 7, the company rating was maintained by Bank of America. The rating was downgraded by Zacks on Monday, August 10 to “Buy”. The stock of Cardinal Health, Inc. (NYSE:CAH) has “Hold” rating given on Wednesday, January 24 by Mizuho. The company was maintained on Thursday, February 8 by RBC Capital Markets. Jefferies maintained the stock with “Hold” rating in Tuesday, August 29 report. Morgan Stanley downgraded the shares of CAH in report on Monday, November 20 to “Underweight” rating. Needham initiated Cardinal Health, Inc. (NYSE:CAH) on Tuesday, April 4 with “Hold” rating. The firm has “Conviction Buy” rating given on Monday, March 7 by Goldman Sachs. The stock has “Market Perform” rating by Raymond James on Wednesday, January 6.

Since January 22, 2018, it had 0 insider purchases, and 2 insider sales for $3.27 million activity. On Wednesday, February 14 the insider MORRISON PATRICIA sold $1.89 million. Kaufmann Michael C sold $1.37M worth of Cardinal Health, Inc. (NYSE:CAH) on Monday, January 22.

Analysts await Macerich Company (NYSE:MAC) to report earnings on April, 26. They expect $0.86 EPS, down 1.15% or $0.01 from last year’s $0.87 per share. MAC’s profit will be $129.88M for 17.26 P/E if the $0.86 EPS becomes a reality. After $1.13 actual EPS reported by Macerich Company for the previous quarter, Wall Street now forecasts -23.89% negative EPS growth.

The stock decreased 0.90% or $0.54 during the last trading session, reaching $59.38. About 1.12M shares traded. Macerich Company (MAC) has declined 18.62% since February 21, 2017 and is downtrending. It has underperformed by 35.32% the S&P500.

Leave a Reply

Your email address will not be published. Required fields are marked *